These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 11416232)
1. Height, bone mineral density and bone markers in congenital adrenal hyperplasia. Paganini C; Radetti G; Livieri C; Braga V; Migliavacca D; Adami S Horm Res; 2000; 54(4):164-8. PubMed ID: 11416232 [TBL] [Abstract][Full Text] [Related]
2. Early growth, pubertal development, body mass index and final height of patients with congenital adrenal hyperplasia: factors influencing the outcome. Manoli I; Kanaka-Gantenbein Ch; Voutetakis A; Maniati-Christidi M; Dacou-Voutetakis C Clin Endocrinol (Oxf); 2002 Nov; 57(5):669-76. PubMed ID: 12390343 [TBL] [Abstract][Full Text] [Related]
3. Growth patterns and final height in congenital adrenal hyperplasia due to classical 21-hydroxylase deficiency. Results of a multicenter study. Hargitai G; Sólyom J; Battelino T; Lebl J; Pribilincová Z; Hauspie R; Kovács J; Waldhauser F; Frisch H; Horm Res; 2001; 55(4):161-71. PubMed ID: 11598369 [TBL] [Abstract][Full Text] [Related]
4. Bone mineral density in prepubertal and in adolescent and young adult patients with the salt-wasting form of congenital adrenal hyperplasia. Gussinyé M; Carrascosa A; Potau N; Enrubia M; Vicens-Calvet E; Ibáñez L; Yeste D Pediatrics; 1997 Oct; 100(4):671-4. PubMed ID: 9310523 [TBL] [Abstract][Full Text] [Related]
5. Altered bone mineral density in patients with complete androgen insensitivity syndrome. Bertelloni S; Baroncelli GI; Federico G; Cappa M; Lala R; Saggese G Horm Res; 1998; 50(6):309-14. PubMed ID: 9973670 [TBL] [Abstract][Full Text] [Related]
6. Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia. Guo CY; Weetman AP; Eastell R Clin Endocrinol (Oxf); 1996 Nov; 45(5):535-41. PubMed ID: 8977749 [TBL] [Abstract][Full Text] [Related]
7. Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty. Bonfig W; Bechtold S; Schmidt H; Knorr D; Schwarz HP J Clin Endocrinol Metab; 2007 May; 92(5):1635-9. PubMed ID: 17299071 [TBL] [Abstract][Full Text] [Related]
8. Bone mineral density and body composition in prepubertal and adolescent patients with the classical form of 21-hydroxylase deficiency. Sahakitrungruang T; Wacharasindhu S; Supornsilchai V; Srivuthana S; Kingpetch K J Med Assoc Thai; 2008 May; 91(5):705-10. PubMed ID: 18672636 [TBL] [Abstract][Full Text] [Related]
9. Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a cross-sectional study of factors involved in bone mineral density. de Almeida Freire PO; de Lemos-Marini SH; Maciel-Guerra AT; Morcillo AM; Matias Baptista MT; de Mello MP; Guerra G J Bone Miner Metab; 2003; 21(6):396-401. PubMed ID: 14586796 [TBL] [Abstract][Full Text] [Related]
10. Effect of puberty on the relationship between bone markers of turnover and bone mineral density in Turner's syndrome. Gallicchio CT; Figueiredo-Alves ST; Prendin Tórtora R; Mendonça LM; Farias ML; Guimarães MM Horm Res; 2004; 61(4):193-9. PubMed ID: 14752210 [TBL] [Abstract][Full Text] [Related]
11. Growth curves for congenital adrenal hyperplasia from a national retrospective cohort. Bretones P; Riche B; Pichot E; David M; Roy P; Tardy V; Kassai B; Gaillard S; Bernoux D; Morel Y; Chatelain P; Nicolino M; Cornu C; J Pediatr Endocrinol Metab; 2016 Dec; 29(12):1379-1388. PubMed ID: 27852974 [TBL] [Abstract][Full Text] [Related]
12. Bone mineral density and body composition in congenital adrenal hyperplasia. Cameron FJ; Kaymakci B; Byrt EA; Ebeling PR; Warne GL; Wark JD J Clin Endocrinol Metab; 1995 Jul; 80(7):2238-43. PubMed ID: 7608286 [TBL] [Abstract][Full Text] [Related]
13. Growth pattern of untreated boys with simple virilizing congenital adrenal hyperplasia indicates relative androgen insensitivity during the first six months of life. Bonfig W; Schwarz HP Horm Res Paediatr; 2011; 75(4):264-8. PubMed ID: 21196707 [TBL] [Abstract][Full Text] [Related]
14. The relation of peripubertal and pubertal growth to final adult height in children with classic congenital adrenal hyperplasia. Bomberg EM; Addo OY; Kyllo J; Gonzalez-Bolanos MT; Ltief AM; Pittock S; Himes JH; Miller BS; Sarafoglou K J Pediatr; 2015 Mar; 166(3):743-50. PubMed ID: 25557963 [TBL] [Abstract][Full Text] [Related]
15. Bone mineral status, bone turnover markers and vitamin D status in children with congenital adrenal hyperplasia. Okten A; Cakir M; Makuloglu M Minerva Endocrinol; 2012 Sep; 37(3):275-82. PubMed ID: 22766894 [TBL] [Abstract][Full Text] [Related]
16. Volumetric bone mineral density in normal subjects, aged 5-27 years. Lu PW; Cowell CT; LLoyd-Jones SA; Briody JN; Howman-Giles R J Clin Endocrinol Metab; 1996 Apr; 81(4):1586-90. PubMed ID: 8636372 [TBL] [Abstract][Full Text] [Related]
17. Fractures and bone mineral density in adult women with 21-hydroxylase deficiency. Falhammar H; Filipsson H; Holmdahl G; Janson PO; Nordenskjöld A; Hagenfeldt K; Thorén M J Clin Endocrinol Metab; 2007 Dec; 92(12):4643-9. PubMed ID: 17878254 [TBL] [Abstract][Full Text] [Related]
18. Effects of projective bone area size of the spine on bone density and the diagnosis of osteoporosis in healthy pre-menopausal women in China. Wu XP; Liao EY; Dai RC; Luo XH; Zhang H Br J Radiol; 2003 Jul; 76(907):452-8. PubMed ID: 12857704 [TBL] [Abstract][Full Text] [Related]
19. The effects of glucocorticoid replacement therapy on growth, bone mineral density, and bone turnover markers in children with congenital adrenal hyperplasia. Girgis R; Winter JS J Clin Endocrinol Metab; 1997 Dec; 82(12):3926-9. PubMed ID: 9398689 [TBL] [Abstract][Full Text] [Related]
20. Reduced bone mineral density and increased bone metabolism rate in young adult patients with 21-hydroxylase deficiency. Sciannamblo M; Russo G; Cuccato D; Chiumello G; Mora S J Clin Endocrinol Metab; 2006 Nov; 91(11):4453-8. PubMed ID: 16926248 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]